The Latest Cardiac and Vascular News
DANVERS, Mass., April 02, 2018 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella CP®heart pump with SmartAssistTM, utilizing an optical sensor. At the forefront […]
CHICAGO, March 29, 2018 /PRNewswire/ — A Northwestern Memorial Hospital cardiac surgeon helped pioneer the use of an U.S. Food and Drug Administration (FDA) approved aortic valve ring as part of a triple valve repair, the first of its kind in the United States. S. Chris Malaisrie, MD, has performed two successful surgeries using the […]
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Mar 29, 2018 — Novoheart (“Novoheart” or the “Company”) (TSX VENTURE: NVH)(FRANKFURT: 3NH) is pleased to announce that it has filed a patent application on the use of its proprietary MyHeart™ Platform of human bioengineered heart tissues to create disease models for neurological diseases in which […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, today announced the appointment of Marc de Garidel as Chief Executive Officer. Mr. de Garidel succeeds Corvidia’s Michael Davidson, M.D., who will remain on the company’s executive team as Chief Scientific Officer. “As we transition from a clinical stage […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, has received CE Mark approval for its Bicarbon® aortic valves for use with low-dose anticoagulant therapy. The expanded CE labeling means that a lower international normalized ratio (INR), the standardized index used to measure blood coagulability, can be […]
LONDON, March 28, 2018 /PRNewswire/ — Download the full report: https://www.reportbuyer.com/product/5360520 The global cardiac resynchronization therapy (CRT) market is expected to reach USD 9.2 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiac disorders and rising incidences of heart failure are expected to boost the CRT market […]
DUBLIN–(BUSINESS WIRE)– The “Global Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. Electrocardiograph (ECG) Market was valued at $5 billion in 2016, and is estimated to reach $7 billion by 2023, growing at a CAGR of 5.8% during the forecast period. Technological advancements of ECG devices such as their portability, […]
BOCA RATON, Fla., March 27, 2018 /PRNewswire/ — New research from MDVIP and Cleveland HeartLab finds that patients with diabetes, pre-diabetes or no evidence of diabetes whose physicians ordered myeloperoxidase (MPO) inflammation testing achieved sharp reductions in MPO levels over five years. The investigators theorize the levels declined over time as a result […]
SAN DIEGO, March 27, 2018 /PRNewswire/ — Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that the European Patent Office has issued Patent No. 2814513, “Systemic Delivery and Regulated Expression of Paracrine Genes for Cardiovascular Diseases and Other Conditions” to The Regents of the […]
WASHINGTON, March 23, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the United States Patent and Trademark Office (USPTO) decided in Edwards’ favor in an Inter Partes Review (IPR) of Boston Scientific’s U.S. transcatheter heart valve patent, […]
